Cell-to-cell communication is essential throughout all forms and stages of life, and many communication mechanisms are well ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

SINGAPORE - Media OutReach Newswire - 15 February 2025 - A groundbreaking study has revealed that INDIBA Proionic 448kHz + 20kHz technology significa ...

The study demonstrated that applying INDIBA's Proionic System at subthermal levels accelerates tissue regeneration through ...

BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced the completion of enrollment and dosing for the low-dose cohort ...

BioCardia (BCDA) announced completion of enrollment and dosing in the low dose cohort in its CardiALLO Allogeneic Mesenchymal Cell Therapy ...

The Joint Clinical Research Centre (JCRC) at Lubowa in partnership with Asea BioTherapeutics (ABT) today successfully treated their first client with cutting-edge stem cell therapy, marking a historic ...

Vimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

Mr. Iwicki stated, "I am proud of the work we have done at KALA utilizing our MSC-S platform, and I am very excited about the ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...